ξεπθμεχΰρθ - ϊψιξδ 5 ξ"β
|
ων δϊψετδ αΰπβμιϊ: Montelukast - Trima 5 Mg.
ξητωιν ϊψετδ ΰηψϊ? λπρε μΰιπγχρ δϊψετεϊ »
|
|
 αρμ δαψιΰεϊ
φεψϊ ξϊο
PER OS
ξιπεο
Chewable Tablets
ωιξεω αϊψετδ
Montelukast - Trima is indicated in adult and pediatric patients 2 years of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treatment of aspirin-sensitive asthmatic patients, and the prevention of exercise-induced bronchoconstriction. Montelukast - Trima is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. Montelukast - Trima and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. Montelukast - Trima is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.
ξρτψ ψιωεν
146 93 33403 00
ιφψο
Trima Israel Pharmaceutical Products Maabarot Ltd, Israel
ϊεχσ ψιωιεο μϊψετδ
11/2011 - 10/2016
ηεξψ τςιμ
|
ψιλεζ / λξεϊ αιηιγϊ ξιπεο
|
Montelukast as sodium salt |
5 MG |
ΰψιζδ
|
λξεϊ αΰψιζδ
|
ηιι ξγσ
|
ϊψετϊ ξψων
|
Blister aluminium /aluminium |
28 x TABLETS |
ηεγωιν 24 |
λο |
λμ ξϊλεο αΰϊψ ξλιμ ςψλιν ϊζεπϊιιν ξμΰιν! μξϊλεπιν »
|
|
|